Abstract
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shenker JG, Weinstein D. OHSS. A current survey. Fertil Steril. 1978;30:255–68.
Serour GI, Aboulghar M, Mansour R. Complications of medically assisted conception in 3500 cycles. Fertil Steril. 1998;70:638–42.
Nyboe A, et al. ESHRE report on ART in Europe found an incidence of OHSS of 1.2 % of all stimulated cycles. Hum Reprod. 2004;23:756–71.
Institute Obstetricians & Gynaecologist. Royal College of Physicians of no. 9; rev Ireland. Directorate of Strategy & Clinical Programmes. Health Service Executive; Ovarian hyperstimulation Syndrome Diagnosis & Management; version 1; guideline. Clinical practice guidelines. 2014.
Courbiere B, Oborski V, Braunstein D, Desparoir A, Noizet A. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril. 2011;95:1629–32. 2011 by American Society for Reproductive Medicine.
Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997;3:255–66.
Kamada S, Kubota T, Taguchi M, Aso T. High levels of immunoreactive endothelin-1 in human follicular fluids. Hum Reprod. 1993;8:674–7.
Rogers RG, Thorp Jr JM. Pregnancy-induced hypertension: genesis of and response to endothelial injury and the role of endothelin 1. Obstet Gynecol Surv. 1997;52:723–7.
Mathur RS, Jenkins JM. Is ovarian hyperstimulation syndrome associated with a poor obstetric outcome? Br J Obstet Gynecol. 2000;107:943–6.
Abramov Y, Elchalal U, Schenker JG. Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril. 1998;70:1070–6.
Bastek JA, Brown AG, Anton L, Srinivas SK, D’Addio A, Elovitz MA. Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth. J Matern Fetal Neonatal Med. 2011;24(4):600–5.doi: 10.3109/14767058.2010.511340. Epub 2010 Sep 7.
Hass J, Bavem M, Meridor H. In severe OHSS associated with adverse pregnancy outcomes? Evidence from a case control studies. Reprod Biomed Online. 2004;29(2):216–21.
Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet. 2001;75:221–8.
Wiser A, Levron J, Kreizer D, Achiron R, Shrim A. Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester. Hum Reprod. 2005;20(4):910–4.
Das M, Son WY, Bucket W. In vitro maturation versus IVF with GnRH antagonist for women with PCOS, treatment outcome and rates of OG + HSS. Reprod Biomed online. 2014;29(5):545–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
Pai, R., Pai, H., Palshtetar, N., Gangurde, P. (2016). Ovarian Hyperstimulation Syndrome and Pregnancy. In: Gandhi, A., Malhotra, N., Malhotra, J., Gupta, N., Bora, N. (eds) Principles of Critical Care in Obstetrics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2686-4_32
Download citation
DOI: https://doi.org/10.1007/978-81-322-2686-4_32
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2684-0
Online ISBN: 978-81-322-2686-4
eBook Packages: MedicineMedicine (R0)